Treatment with melatonin enhances ER stress–mediated apoptosis in tunicamycin-treated cancer cells; this effect is associated with the down-regulation of COX-2 and Bcl-2 expressions and up-regulation of Bim, CHOP and Bax expressions [73]. This evidence concerns the gene BCL2 and cancer.